Precise Control of Glioma Cell Apoptosis Induced by Micro-Plasma-Activated Water (μ-PAW)

Abstract

To verify the existence of plasma with the potential to kill tumor cells, this paper designed a novel helium (He) micro-plasma jet array device and detected the concentration of typical long-lived reactive oxygen and nitrogen species (RONS) with oxidative activity generated by it. The paper described a new He micro-plasma jet array device consisting of nine flexible quartz capillaries with an inner diameter of 75 μm arranged in a 3 × 3 array. Sterilized ultrapure water (up water) was first treated with the He micro-plasma jet array device to activate it to form enriched RONS micro-plasma-activated water (μ-PAW), and then μ-PAW was added to the cell culture medium (with cells) to observe the proliferation of human glioma cells. The concentration of long-lived RONS, such as nitrate (NO3−), was detected according to Beer–Lambert’s law in combination with UV spectrophotometry as well as a color development method. The MTT Cell Proliferation and Cytotoxicity Assay Kit combined with the Hoechst Staining Kit were used to assess the proliferation status of the cells. The results showed that the range of RONS concentration variation could be controlled in the order of micromoles (µmol), while plasma-induced tumor cell death is apoptosis that does not affect the surrounding environment.

Cold atmospheric plasma (CAP) treatment increased reactive oxygen and nitrogen species (RONS) levels in tumor samples obtained from patients with low-grade glioma

“…The discovery of anticancer properties of CAP has led investigations into its effects on various types of tumors and their underlying mechanisms. It has been observed to effectively induce cancer cell death in numerous human cancer cell lines, including those from the brain [10], hepatoma [11], breast [12], pancreatic [13], colorectal [14], lung cancer [15], leukemia [16], and squamous cell carcinoma (SCC) [17]. The specificity of CAP towards cancer cells makes it a promising alternative to conventional treatments.…”